543P Tumor Mutational Burden (TMB), BRAF Status, and C-reactive Protein (CRP) Predict Response to First-Line Alternating Oxaliplatin-Based Chemotherapy and Nivolumab in Metastatic Microsatellite-Stable (MSS) Colorectal Cancer (CRC)

A.H. Ree, P.A. Bousquet, H.L. Nilsen, T. Lüders, S. Wang, T. Visnovska, D.L. Bordin, E. Høye, H.M. Hamre,C. Kersten,E. Hofsli,M.G. Guren,H. Sorbye,J.P. Berg,K. Flatmark,S. Meltzer

Annals of Oncology（2024）

Cited 0|Views1

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined